Cranmer, L. D., K. T. Tr evor, et al. (2004). "Clinical applications of dendritic cell vaccination in the treatment of ca ncer." Cancer Immunol Immunother 53(4): 275- 306. Protocol # CL-PTL 105 CONFIDENTIAL AM #9 09/25/15 Page 80 40. Dallas, S. L., S. Zhao, et al. (2005). "P referential production of latent transforming growth factor beta-2 by pr imary prostatic epithelial ce lls and its activation by prostate-specific antigen." J Cell Physiol 202(2): 361-70. 41. Darrow, T. L., C. L. Sli ngluff, Jr., et al. (1989). "The ro le of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens." J Immunol 142(9): 3329-35. 42. Dohadwala, M., J. Luo, et al. (2001). "Non-small cell lung cancer cyclooxygenase-2-dependent in vasion is mediated by CD44." J Biol Chem 276(24): 20809-12. 43. Dranoff, G. (2004). "Cytokines in c ancer pathogenesis and canc er therapy." Nat Rev Cancer 4 (1): 11-22. 44. Dranoff, G., E. Jaffee, et al. (1993). "Vaccination with irradiated tumor cells engineered to secrete murine granulocyte- macrophage colony-stimulating factor stimulates potent, specific, and long-lasti ng anti-tumor immunity ." Proc Natl Acad Sci U S A 90(8): 3539-43. 45.